Gsa Capital Partners LLP Pfizer Inc Transaction History

Gsa Capital Partners LLP

$1.11 Billion
Q1 2025

A detailed history of Gsa Capital Partners LLP transactions in Pfizer Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 122,036 shares of PFE stock, worth $2.88 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

122,036

Previous 19,888 513.62%

Holding current value

$2.88 Million

Previous $528,000 485.61%

% of portfolio

0.28%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$25.01 - $27.13 $2.55 Million - $2.77 Million	102,148 Added 513.62%	122,036 $3.09 Million
Q4 2024 Feb 07, 2025	SELL	$24.8 - $30.19 $319,870 - $389,390	-12,898 Reduced 39.34%	19,888 $528,000
Q3 2024 Nov 05, 2024	BUY	$27.7 - $31.39 $424,087 - $480,580	15,310 Added 87.61%	32,786 $949,000
Q2 2024 Aug 15, 2024	BUY	$25.26 - $29.6 $41,679 - $48,840	1,650 Added 10.43%	17,476 $489,000
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $409,735 - $470,506	15,826 New	15,826 $439,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $293,717 - $358,555	6,712 New	6,712 $294,000
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $1.19 Million - $1.41 Million	-25,510 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $997,624 - $1.24 Million	21,806 Added 588.71%	25,510 $1.32 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $334,939 - $496,492	-8,106 Reduced 68.64%	3,704 $219,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $463,542 - $595,460	11,810 New	11,810 $508,000
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $276,526 - $311,866	-8,257 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $276,361 - $351,417	8,257 New	8,257 $304,000
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $183,804 - $262,616	-6,800 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $203,182 - $230,585	-6,172 Reduced 47.58%	6,800 $266,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $421,460 - $546,510	12,972 New	12,972 $466,000
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $621,264 - $697,536	-16,800 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $370,875 - $407,468	-9,890 Reduced 37.06%	16,800 $713,000
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $51,318 - $58,509	-1,334 Reduced 4.76%	26,690 $1.17 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $624,148 - $757,053	18,107 Added 182.59%	28,024 $1.24 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $327,062 - $348,681	9,917 New	9,917 $360,000
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $1.87 Million - $2.17 Million	-58,604 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $1.95 Million - $2.07 Million	58,604	58,604 $2.12 Million

Others Institutions Holding PFE

# of Institutions

3,365

Shares Held

3.6B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $133B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Pfizer Inc Transaction History